Last10K.com

Zymeworks Inc. (ZYME) SEC Filing 425 Merger Prospectus

Zymeworks Inc.

CIK: 1403752 Ticker: ZYME

View differences made from one to another to evaluate Zymeworks Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 425 Merger Prospectus to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Zymeworks Inc..

Continue

Assess how Zymeworks Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Zymeworks Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: ZYME
CIK: 1403752
Form Type: 425 Merger Prospectus
Accession Number: 0001193125-22-195140
Submitted to the SEC: Fri Jul 15 2022 5:19:51 PM EST
Accepted by the SEC: Fri Jul 15 2022
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/zyme/0001193125-22-195140.htm